Valeria Cnossen

General Counsel en GALAPAGOS NV .

51 años

Health Technology

Perfil

Valeria Cnossen is currently the Executive Vice President & General Counsel at Galapagos NV.
Prior to her current position, she served as the Head-Legal & Compliance at Crucell NV and as the General Counsel-Consumer Health Group at Johnson & Johnson Consumer NV.

Cargos activos de Valeria Cnossen

Empresas	Cargo	Inicio
GALAPAGOS NV	General Counsel	01/01/2023

Todos los cargos activos de Valeria Cnossen

Antiguos cargos conocidos de Valeria Cnossen.

Empresas	Cargo	Fin
Johnson & Johnson Consumer NV	Corporate Officer/Principal	-
Crucell NV Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.	Compliance Officer	-

Ver el detalle de la experiencia de Valeria Cnossen.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Valeria Cnossen.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
GALAPAGOS NV	Health Technology

Empresas privadas	2
Crucell NV Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.	Health Technology
Johnson & Johnson Consumer NV